Glucagon-like Peptide-1 Receptor Agonists and Risk for Ischemic Optic Neuropathy
Annals of Internal Medicine · 2026
DOI: 10.7326/annals-25-00860 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Annals of Internal Medicine, 2026. Verfasst von Kamika R Reynolds und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick…. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists, Diabetes Mellitus, Type 2, Optic Neuropathy, Ischemic, Dipeptidyl-Peptidase IV Inhibitors. Die Arbeit nennt 35 Literaturangaben. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, NHLBI.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, New Jersey, and Center for Health Outcomes, Policy, and Economics, E…
- Department of Biostatistics and Epidemiology, Rutgers School of Public Health, New Brunswick, New Jersey (J.A.R.).
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
- NHLBI
- NIDDK
Zitieren
APA
Reynolds, K. R., O'Malley, K. M., Roy, J. A., & Dave, C. V. (2026). Glucagon-like Peptide-1 Receptor Agonists and Risk for Ischemic Optic Neuropathy. Annals of Internal Medicine. https://doi.org/10.7326/annals-25-00860
Vancouver
Reynolds KR, O'Malley KM, Roy JA, Dave CV. Glucagon-like Peptide-1 Receptor Agonists and Risk for Ischemic Optic Neuropathy. Annals of Internal Medicine. 2026. doi:10.7326/annals-25-00860
BibTeX
@article{Reynolds2026,
author = {Reynolds, Kamika R and O'Malley, Kimberly M and Roy, Jason A and Dave, Chintan V},
title = {Glucagon-like Peptide-1 Receptor Agonists and Risk for Ischemic Optic Neuropathy},
journal = {Annals of Internal Medicine},
year = {2026},
doi = {10.7326/annals-25-00860}
}
EUVIMED